Edwards Lifesciences said Wednesday its transcatheter aortic valve replacement (TAVR) device is similarly effective in patients with small and large aortic annuli.
Earlier this year, Medtronic linked its TAVR device to a lower rate of valve dysfunction than Edwards’ rival product in people with small annuli.
